Skip to main content
. 2022 Apr 23;12:6674. doi: 10.1038/s41598-022-10692-0

Figure 1.

Figure 1

Discovery of asteltoxin, a new EV secretion inhibitor, from fungi extracts using cancer cells engineered to secrete luciferase-labeled EVs. (A) Chemical structure of asteltoxin. (B) HT29/CD63-Nluc cells were treated with different concentrations of asteltoxin for 24 h, and luminescence in the culture medium was analyzed (blue). Simultaneously, cell growth was analyzed using the WST-8 assay (orange). The relative percentages of luminescence were compared to the DMSO control (100%). (C) PC3 expressing CD63-Antares2 cells (PC3/CD63-Antares2) were treated with DMSO or asteltoxin at the indicated concentrations for 24 h, and luminescence in the culture medium was analyzed. Data are presented as the means ± standard deviation for three independent measurements. Statistical analysis was performed using one-way ANOVA. **P < 0.01.